Skip to content

Clinical trials

Phase 1 Rectal Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20091
20101
20171
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Adlai Nortye Biopharma Co., Ltd.1
Cancer Research UK1
Novartis Pharmaceuticals1
Seagen, a wholly owned subsidiary of Pfizer1
The Christie NHS Foundation Trust1
University of Leicester1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms9
Colonic Neoplasms6
Colorectal Neoplasms6
Carcinoma, Non-Small-Cell Lung2
Adenoviridae Infections1
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Lung Neoplasms1
Neoplasm Metastasis1
Ovarian Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.